-
Something wrong with this record ?
Structural and Functional Characterization of Four Novel Fibrinogen Mutations in FGB Causing Congenital Fibrinogen Disorder
E. Ceznerová, J. Kaufmanová, Ž. Sovová, J. Štikarová, J. Loužil, R. Kotlín, J. Suttnar
Language English Country Switzerland
Document type Case Reports, Journal Article
Grant support
00023736
The Ministry of Health of the Czech Republic
NLK
Free Medical Journals
from 2000
Freely Accessible Science Journals
from 2000
PubMed Central
from 2007
Europe PubMed Central
from 2007
ProQuest Central
from 2000-03-01
Open Access Digital Library
from 2000-01-01
Open Access Digital Library
from 2007-01-01
Health & Medicine (ProQuest)
from 2000-03-01
ROAD: Directory of Open Access Scholarly Resources
from 2000
PubMed
35054908
DOI
10.3390/ijms23020721
Knihovny.cz E-resources
- MeSH
- Afibrinogenemia blood diagnosis genetics MeSH
- Phenotype * MeSH
- Fibrinogen chemistry genetics metabolism MeSH
- Genetic Predisposition to Disease * MeSH
- Genetic Association Studies MeSH
- Blood Coagulation MeSH
- Protein Conformation MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Models, Molecular MeSH
- Mutation * MeSH
- DNA Mutational Analysis MeSH
- Infant, Newborn MeSH
- Aged MeSH
- Blood Coagulation Tests MeSH
- Structure-Activity Relationship MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Male MeSH
- Infant, Newborn MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
Congenital fibrinogen disorders are caused by mutations in genes coding for fibrinogen and may lead to various clinical phenotypes. Here, we present a functional and structural analysis of 4 novel variants located in the FGB gene coding for fibrinogen Bβ chain-heterozygous missense BβY416C and BβA68S, homozygous nonsense BβY345*, and heterozygous nonsense BβW403* mutations. The cases were identified by coagulation screening tests and further investigated by various methods. Fibrin polymerization had abnormal development with decreased maximal absorbance in all patients. Plasmin-induced fibrin degradation revealed different lytic phases of BβY416C and BβW403* than those of the control. Fibrinopeptide cleavage measured by reverse phase high pressure liquid chromatography of BβA68S showed impaired release of fibrinopeptide B. Morphological properties, studied through scanning electron microscopy, differed significantly in the fiber thickness of BβY416C, BβA68S, and BβW403*, and in the fiber density of BβY416C and BβW403*. Finally, homology modeling of BβA68S showed that mutation caused negligible alternations in the protein structure. In conclusion, all mutations altered the correct fibrinogen function or structure that led to congenital fibrinogen disorders.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22011360
- 003
- CZ-PrNML
- 005
- 20241014101825.0
- 007
- ta
- 008
- 220425s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ijms23020721 $2 doi
- 035 __
- $a (PubMed)35054908
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Ceznerová, Eliška $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, U Nemocnice 2094/1, 12800 Prague, Czech Republic $u Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, Technická 5, 16628 Prague, Czech Republic $1 https://orcid.org/0000000210725967
- 245 10
- $a Structural and Functional Characterization of Four Novel Fibrinogen Mutations in FGB Causing Congenital Fibrinogen Disorder / $c E. Ceznerová, J. Kaufmanová, Ž. Sovová, J. Štikarová, J. Loužil, R. Kotlín, J. Suttnar
- 520 9_
- $a Congenital fibrinogen disorders are caused by mutations in genes coding for fibrinogen and may lead to various clinical phenotypes. Here, we present a functional and structural analysis of 4 novel variants located in the FGB gene coding for fibrinogen Bβ chain-heterozygous missense BβY416C and BβA68S, homozygous nonsense BβY345*, and heterozygous nonsense BβW403* mutations. The cases were identified by coagulation screening tests and further investigated by various methods. Fibrin polymerization had abnormal development with decreased maximal absorbance in all patients. Plasmin-induced fibrin degradation revealed different lytic phases of BβY416C and BβW403* than those of the control. Fibrinopeptide cleavage measured by reverse phase high pressure liquid chromatography of BβA68S showed impaired release of fibrinopeptide B. Morphological properties, studied through scanning electron microscopy, differed significantly in the fiber thickness of BβY416C, BβA68S, and BβW403*, and in the fiber density of BβY416C and BβW403*. Finally, homology modeling of BβA68S showed that mutation caused negligible alternations in the protein structure. In conclusion, all mutations altered the correct fibrinogen function or structure that led to congenital fibrinogen disorders.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a afibrinogenemie $x krev $x diagnóza $x genetika $7 D000347
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a hemokoagulace $7 D001777
- 650 _2
- $a vyšetření krevní srážlivosti $7 D001780
- 650 _2
- $a mutační analýza DNA $7 D004252
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a fibrinogen $x chemie $x genetika $x metabolismus $7 D005340
- 650 _2
- $a genetické asociační studie $7 D056726
- 650 12
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a molekulární modely $7 D008958
- 650 12
- $a mutace $7 D009154
- 650 12
- $a fenotyp $7 D010641
- 650 _2
- $a konformace proteinů $7 D011487
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kaufmanová, Jiřina $u Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, Technická 5, 16628 Prague, Czech Republic $1 https://orcid.org/0000000303378204
- 700 1_
- $a Sovová, Žofie $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, U Nemocnice 2094/1, 12800 Prague, Czech Republic $1 https://orcid.org/000000033337321X
- 700 1_
- $a Štikarová, Jana $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, U Nemocnice 2094/1, 12800 Prague, Czech Republic $1 https://orcid.org/0000000259640526
- 700 1_
- $a Loužil, Jan, $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, U Nemocnice 2094/1, 12800 Prague, Czech Republic $d 1980- $7 xx0324132
- 700 1_
- $a Kotlín, Roman $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, U Nemocnice 2094/1, 12800 Prague, Czech Republic
- 700 1_
- $a Suttnar, Jiří $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, U Nemocnice 2094/1, 12800 Prague, Czech Republic $1 https://orcid.org/0000000343059718
- 773 0_
- $w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 23, č. 2 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35054908 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20241014101823 $b ABA008
- 999 __
- $a ok $b bmc $g 1789107 $s 1162558
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 23 $c 2 $e 20220110 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
- GRA __
- $a 00023736 $p The Ministry of Health of the Czech Republic
- LZP __
- $a Pubmed-20220425